Executive Summary: Therapeutic Monitoring of Vancomycin for Serious Methicillin-Resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists.

Rybak, Michael J; Le, Jennifer; Lodise, Thomas P; Levine, Donald P; Bradley, John S; Liu, Catherine; Mueller, Bruce A; Pai, Manjunath P; Wong-Beringer, Annie; Rotschafer, John C; Rodvold, Keith A; Maples, Holly D; Lomaestro, Ben

Executive Summary: Therapeutic Monitoring of Vancomycin for Serious Methicillin-Resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists.

Issue Date

7/13/2020

Authors

Rybak, Michael J

Le, Jennifer

Lodise, Thomas P

Levine, Donald P

Bradley, John S

Liu, Catherine

Mueller, Bruce A

Pai, Manjunath P

Wong-Beringer, Annie

Rotschafer, John C

Show 3 more

Citation

Rybak MJ, Le J, Lodise T, Levine D, Bradley J, Liu C, Mueller B, Pai M, Wong-Beringer A, Rotschafer JC, Rodvold K, Maples HD, Lomaestro BM. Executive Summary: Therapeutic Monitoring of Vancomycin for Serious Methicillin-Resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists. J Pediatric Infect Dis Soc. 2020 Jul 13;9(3):281-284. doi: 10.1093/jpids/piaa057. PMID: 32659787; PMCID: PMC7358040.